Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1371-1381

  Bracey, Tim S ^a   Williams, Ann C ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; COLORECTAL CANCER; ETIOLOGY; HUMAN; HUMAN CELL; IONIZING RADIATION; MUTAGENESIS; PRIORITY JOURNAL; RADIOSENSITIZATION;

ADENOMA; AMINO ACID SUBSTITUTION; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL SURVIVAL; CESIUM RADIOISOTOPES; COLORECTAL NEOPLASMS; G2 PHASE; GENES, P53; GIANT CELLS; HUMANS; POINT MUTATION; RADIATION, IONIZING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030802463     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Lee, J. M., and Bernstein, A. P53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA, 90: 5742-5746, 1993.
2. Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, A., Lane, D. P., and Hall, P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54: 614-617, 1994.
3. Clarke, A. R., Gledhill, S., Hooper, M. L., Bird, C. C., and Wyllie, A. H. p53 dependence or early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene, 9: 1767-1773, 1994.
4. O'Connor, P. M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I., and Kohn, K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res., 53: 4776-4780, 1993.
5. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
6. Fan, S. J., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O'Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54: 5824-5830, 1994.
7. Bracey, T. S., Miller, J. C., Preece, A., and Paraskeva, C. γ-Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene, 10: 2391-2396, 1995.
8. Strasser, A., Harris, A. W., Jacks, T., and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell, 79: 329-339, 1994.
9. Wu, G. S., and El-Deiry, W. S. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Clin. Cancer Res., 2: 623-633, 1996.
10. 2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol. Cell. Biol., 15: 5849-5857, 1995.
11. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
12. Ohsaki, Y., Ishida, S., Fujikane, T., and Kikuchi, K. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines. Oncology, 53: 327-333, 1996.
13. 2 arrest in Chinese hamster ovary cells. Cancer Res., 50: 3761-3766, 1990.
14. Evans, D. L., and Dive, C. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res., 53: 2133-2139, 1993.
15. Nagasawa, H., Keng, P., Harley, R., Dahlberg, W., and Little, J. B. Relationship between γ-ray-induced G(2)/M delay and cellular radiosensitivity. Int. J. Radiat. Biol., 66: 373-379, 1994.
16. Su, L., and Little, J. B. Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or Simian virus 40 T-antigen. Radiat. Res., 133: 73-79, 1993.
17. 2 checkpoint inhibitor. Clin. Cancer Res., 2: 791-797, 1996.
18. 2 arrest by caffeine. Radiat. Res., 129: 224-227, 1992.
19. Walters, R. A., Gurley, L. R., and Tobey, R. A. Effects of caffeine on radiation-induced phenomena associated with cell-cycle traversal of mammalian cells. Biophys. J., 14: 99-118, 1974.
20. 2 delay. Cancer Res., 55: 1643-1648, 1995.
21. 1 checkpoint-competent cells. Cancer Res., 55: 1639-1642, 1995.
22. 2-phase cell cycle blocks are equally released by caffeine. Radiat. Res., 135: 372-379, 1993.
23. 2 phase arrest in V79 hamster cells: increase of histone messenger RNA levels and p34(cdc2) activation. Cancer Res., 53: 1507-1510, 1993.
24. cdc2 kinase. Nat. Med., 2: 1140-1143, 1996.
25. Smeets, M. F. M. A., Mooren, E. H. M., Abdelwahab, A. H. A., Bartelink, H., and Begg, A. C. Differential repair of radiation-induced DNA damage in cells of human squamous cell carcinoma and the effect of caffeine and cysteamine on induction and repair of DNA double-strand breaks. Radiat. Res., 140: 153-160, 1994.
26. Link, C. J., Jr., Evans, M. K., Cook, J. A., Muldoon, R., Stevnser, T., and Bohr, V. A. Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells. Carcinogenesis (Lond.), 16: 1149-1155, 1995.
27. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
28. Bouffler, S. D., Kemp, C. J., Balmain, A., and Cox, R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res., 55: 3883-3889, 1995.
29. 2-M by p53. Oncogene, 10: 109-115, 1995.
30. 2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene, 10: 2263-2270, 1995.
31. Palayoor, S. T., Macklis, R. M., Bump, E. A., and Coleman, C. N. Modulation of radiation-induced apoptosis and G(2)/M block in murine T-lymphoma cells. Radiat. Res., 141: 235-243, 1995.
32. Radford, I. R., Murphy, T. K., Radley, J. M., and Ellis, S. L. Radiation response of mouse lymphoid and myeloid cell lines. ii. Apoptotic death is shown by all lines examined. Int. J. Radiat. Biol., 65: 217-227, 1994.
33. Bases, R., Mendez, F., and Franklin, W. A. Enhanced repair endonuclease activities from radiation-arrested G(2) phase mammalian cells. Int. J. Radiat. Biol., 65: 591-603, 1994.
34. Lee, J. M., Abrahamson, J. L. A., Kandel, R., Donehower, L. A., and Bernstein, A. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene, 9: 3731-3736, 1994.
35. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
36. Smith, M. L., Chen, I. T., Zhan, Q. M., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene, 10: 1053-1059, 1995.
37. Fan, S. J., Smith, M. L., Rivet, D. J., Duba, D., Zhan, Q. M., Kohn, K. W., Fornace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649-1654, 1995.
38. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
39. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
40. Williams, A. C., Browne, S. J., Yeudal, W. A., Paterson, I. C., Marshall, C. J., Lane, D. P., and Paraskeva, C. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene, 8: 3063-3072, 1993.
41. Paraskeva, C., Buckle, B. G., Sheer, D. G., and Wigley, C. B. The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer, 34: 49-56, 1984.
42. 1 arrest after γ irradiation. Oncogene, 11: 141-149, 1995.
43. Williams, A. C., Browne, S. J., Manning, A. M., Daffada, P., Collard, T. J., and Paraskeva, C. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-β 1. Oncogene, 9: 1479-1485, 1994.
44. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonie tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
45. Kadhim, M. A., Lorimore, S. A., Townsend, K. M. S., Goodhead, D. T., Buckle, V. J., and Wright, E. G. Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells. Int. J. Radiat. Biol., 67: 287-293, 1995.
46. Hendry, J. H., and West, C. M. L. Implications of delayed reproductive cell death (lethal mutations, genomic instability) for the interpretation of tissue responses. Int. J. Radiat. Biol., 68: 363-367, 1995.
47. Mothersill, C., Lyng, F., O'Reilly, S., Harney, J., and Seymour, C. B. Expression of lethal mutations is suppressed in neoplastically transformed cells and after treatment of normal cells with carcinogens. Radiat. Res., 145: 714-721, 1996.
48. Chang, W. P., and Little, J. B. Persistently elevated frequency of spontaneous mutations in the progeny of CHO clones surviving X-irradiation: association with delayed reproductive death phenotype. Mut. Res., 270: 191-199, 1992.
49. Brown, D. C., and Trott, K. R. Clonal heterogeneity in the progeny of HeLa cells which survive X-irradiation. Int. J. Radiat. Biol., 66: 151-155, 1994.
50. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
51. 2-M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood, 86: 1148-1158, 1995.
52. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.
53. 1/2 cells. Oncogene, 13: 1677-1685, 1996.
54. Hall, L. L., Th'ng, J. P. H., Guo, X. W., Teplitz, R. L., and Bradbury, E. M. A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. Cancer Res., 56: 3551-3559, 1996.
55. Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., and Greenberg, A. H. Premature P34(Cdc2) activation required for apoptosis. Science (Washington DC), 263: 1143-1145, 1994.